CRI
ARQT icon

Commonwealth Retirement Investments’s Arcutis Biotherapeutics ARQT Stock Holding History

Commonwealth Retirement Investments’s Portfolio ARQT Stock Details ARQT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.62K Buy
+100
New +$2.33K ﹤0.01% 376
2026
Q1 		– Sell
-100
Closed -$2.9K – 140
2025
Q4 		$2.9K Buy
+100
New +$2.56K ﹤0.01% 381

Other funds holding ARQT

SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $42.4B AUM 181.11% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Commonwealth Retirement Investments's ARQT Position: Q2 2026 in Review

Commonwealth Retirement Investments opened a new position in Arcutis Biotherapeutics (ARQT) in Q2 2026: 100 shares worth $2.62K. The stake represents ﹤0.01% of the portfolio and ranks #376 among its holdings. This is a return to the name: Commonwealth Retirement Investments previously reported a position in ARQT as recently as Q4 2025.

Commonwealth Retirement Investments first reported a position in ARQT in Q4 2025 and has held it in 2 quarters since. The position peaked at $2.9K in Q4 2025. 272 funds tracked by Wall St. Rank hold ARQT as of Q2 2026.

  • Commonwealth Retirement Investments held 100 shares of Arcutis Biotherapeutics worth $2.62K as of Q2 2026.
  • Arcutis Biotherapeutics was a new Commonwealth Retirement Investments position in Q2 2026.
  • Arcutis Biotherapeutics made up ﹤0.01% of Commonwealth Retirement Investments's portfolio in Q2 2026, its #376 holding.
  • Commonwealth Retirement Investments first reported a position in Arcutis Biotherapeutics in Q4 2025 and has held it in 2 quarters since.
  • Commonwealth Retirement Investments's Arcutis Biotherapeutics position peaked at $2.9K in Q4 2025.
  • 272 funds tracked by Wall St. Rank held Arcutis Biotherapeutics as of Q2 2026.

Based on Commonwealth Retirement Investments's 13F filing for Q2 2026, filed 3 Aug 2026.